← All decks
The first 25 slides, exactly as they appear. The full deck has 126 content slides.
Dermatology
Genetic Basis of Cutaneous Diseases
Built from Dermatology, 5th Edition
What’s inside
10 sections · 126 slides
Overview
- Overview of the genetic basis of skin disease
Introduction and classification
From gene discovery to a molecular map of skin disease
- Growth of genodermatosis gene discovery
- ~5000
- Why classify skin disease by molecular defect
- McKusick's Online Mendelian Inheritance in Man (OMIM)
Genotype-phenotype correlations
Why one gene can cause many diseases, and many genes one disease
- Five ways one gene's mutations can diverge
- Allelic heterogeneity: one gene, many diseases
- Domain-specific mutations change the phenotype
- Same gene, different inheritance pattern
- Opposite mutations, opposite diseases
- Mutation type sets disease severity
- Locus heterogeneity: many genes, one disease
- Griscelli syndrome: locus heterogeneity with distinct features
Molecular classification of skin disorders
Grouping genodermatoses by the broken protein or pathway
- Molecular classification of hereditary skin disorders
- Molecular classification of genetic skin disorders.
- Molecular classification of genetic skin disorders. (continued)
- Molecular classification of genetic skin disorders. (continued)
- Molecular classification of genetic skin disorders. (continued)
- Molecular classification of genetic skin disorders. (continued)
- Molecular classification of genetic skin disorders. (continued)
- Molecular classification of genetic skin disorders. (continued)
- Molecular classification of genetic skin disorders. (continued)
- Molecular classification of genetic skin disorders. (continued)
- Molecular classification of genetic skin disorders. (continued)
- Molecular classification of genetic skin disorders. (continued)
- Molecular classification of genetic skin disorders. (continued)
- Molecular classification of genetic skin disorders. (continued)
- Molecular classification of genetic skin disorders. (continued)
- Molecular classification of genetic skin disorders. (continued)
- Molecular classification of genetic skin disorders. (continued)
- Where to find detailed tables for each disease group
- Groups of monogenic skin disorders listed in tables elsewhere in the book.
- Groups of monogenic skin disorders listed in tables elsewhere in the book. (continued)
- Groups of monogenic skin disorders listed in tables elsewhere in the book. (continued)
Structural protein and adhesion defects
Keratins, desmosomes, gap junctions, and matrix adhesion
- Keratin gene defects and their skin diseases
- How keratin pairing explains locus and allelic heterogeneity
- Desmosomes hold skin cells together
- Desmoglein 4 loss causes recessive monilethrix
- Connexins and gap junctions link cell activity
- Connexin disease spectrum and lymphatic connexins
- Hemidesmosomes anchor skin to its basement membrane
- Kindler EB: the one adhesion disease from actin, not keratin
Transporters and the nuclear envelope
Membrane pumps, channels, and the nucleus's own scaffolding
- Transmembrane transporter defects in skin disease
- H syndrome: a nucleoside transporter defect
- Calcium pump defects: Darier and Hailey-Hailey disease
- What the calcium pump genes actually do
- ABC transporters: a shared family, many diseases
- Pseudoxanthoma elasticum: a transporter disease, not a matrix disease
- ABCA12 dose explains harlequin versus lamellar ichthyosis
- Nuclear envelope defects (laminopathies)
- Lamin genes and related nuclear proteins
Signaling pathway defects
Inflammation, tumor growth, RAS/MAPK, and WNT signaling gone wrong
- Pyrin/NOD family defects and autoinflammatory disease
- The autoinflammatory skin-disease spectrum
- Hereditary tumor syndromes: three broken-mechanism types
- Defective DNA repair (caretaker) genes
- Telomere maintenance and dyskeratosis congenita
- Defective tumor suppressor (gatekeeper) genes
- PTEN, PI3K/AKT, AMPK, and cyclic AMP signaling
- Activated oncogenes drive some hereditary tumors
- Hereditary skin disorders with benign skin tumors
- Selected hereditary skin disorders characterized by benign skin tumors.
- Selected hereditary skin disorders characterized by benign skin tumors. (continued)
- Selected hereditary skin disorders characterized by benign skin tumors. (continued)
- Selected hereditary skin disorders characterized by benign skin tumors. (continued)
- Hereditary skin disorders with skin cancer risk
- Selected hereditary disorders associated with skin cancer.
- Selected hereditary disorders associated with skin cancer. (continued)
- Hereditary skin disorders with extracutaneous cancer
- Selected hereditary skin disorders associated with extracutaneous cancer.
- Selected hereditary skin disorders associated with extracutaneous cancer. (continued)
- Selected hereditary skin disorders associated with extracutaneous cancer. (continued)
- Selected hereditary skin disorders associated with extracutaneous cancer. (continued)
- Selected hereditary skin disorders associated with extracutaneous cancer. (continued)
- Selected hereditary skin disorders associated with extracutaneous cancer. (continued)
- Selected hereditary skin disorders associated with extracutaneous cancer. (continued)
- Selected hereditary skin disorders associated with extracutaneous cancer. (continued)
- RASopathies: one pathway, two mutation directions
- RAS-mitogen-activated protein kinase (MAPK) signaling
- Shared features across RASopathies
- Costello syndrome: a distinct RASopathy
- Targeted therapy in the RAS-MAPK pathway
- WNT/beta-catenin signaling in the skin
- WNT/beta-catenin signaling pathway
- Goltz syndrome: a PORCN defect
- WNT10A, Gardner syndrome, and R-spondins
Contiguous gene syndromes and mosaicism
When a deletion spans several genes, or a mutation only reaches part of the body
- Contiguous gene syndromes
- More examples of contiguous gene syndromes
- What mosaicism means in skin disease
- Mosaic signaling mutations cause common birthmarks
- Type 1 versus type 2 mosaicism
- Confirmed examples of type 1 and type 2 mosaicism
- FGFR3 defects: germline versus mosaic mutation
- Type 2 segmental Hailey-Hailey disease
- X-inactivation creates 'functional mosaics'
- X-linked dominant, male-lethal disorders in female carriers
- Female carriers of X-linked hypohidrotic ectodermal dysplasia
- IFAP syndrome: ichthyosis, hair loss, light sensitivity
- Revertant mosaicism: the body's own gene correction
- How revertant mosaicism corrects a mutation
- Ichthyosis en confetti: revertant mosaicism in action
Chromosomal disorders
When a whole extra or missing chromosome changes the skin
- Aneuploidy: extra or missing chromosomes
- Skin findings associated with chromosomal aberrations.
- Skin findings associated with chromosomal aberrations. (continued)
- Skin findings associated with chromosomal aberrations. (continued)
- Down syndrome: skin and mucosal findings
- Phylloid hypomelanosis: mosaic trisomy 13
Insights, diagnosis, and treatment
What genodermatoses teach us about common disease, and how understanding leads to therapy
- Rare gene defects explain common autoimmune skin disease
- Wound healing and autoantibody discoveries from rare disease
- Interferonopathies inform lupus and dermatomyositis therapy
- Filaggrin, atopic dermatitis, and asthma
- SPINK5 and Netherton syndrome inform atopic dermatitis
- Prenatal diagnosis has moved from skin biopsy to DNA testing
- Modern prenatal and preimplantation testing options
- Gene therapy for epidermolysis bullosa
- In vivo gene therapy and gene editing for EB
- Targeting the mTOR pathway: sirolimus and everolimus
- More pathway-targeted therapies for genodermatoses
- Key takeaways
- References
- References (continued)
- References (continued)
- References (continued)
- References (continued)
- References (continued)
- References (continued)
- Dermatology, 5th Edition (2-Volume Set)